Ad
related to: drospirenone indications for diabetes drug resistance treatment- Dosing & Prescribing
Learn More About Starting
Your Patients on NEXTSTELLIS®.
- Why NEXTSTELLIS®
Learn More About NEXTSTELLIS®
& Its Tolerability. Visit HCP Site.
- NEXTSTELLIS® Safety
Visit HCP Site for the Long-Term
Safety Profile of NEXTSTELLIS®.
- NEXTSTELLIS® Efficacy
Visit HCP Site for Safety &
Efficacy Info on NEXTSTELLIS®.
- Dosing & Prescribing
Search results
Results from the WOW.Com Content Network
Drospirenone is a progestin and antiandrogen medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses. [1] [10] It is available both alone under the brand name Slynd and in combination with an estrogen under the brand name Yasmin among others.
Drospirenone/estetrol, sold under the brand name Nextstellis, among others, is a fixed-dose combination medication containing drospirenone, a progestin, and estetrol, an estrogen, which is used as a combined birth control pill for the prevention of pregnancy in women. [2] [6] It is taken by mouth. [2] [6]
In addition to a single-drug formulation, estetrol is being developed in combination with the progestin drospirenone for hormonal contraception (use as a birth control pill) to prevent pregnancy. Drospirenone is a potent antimineralocorticoid and antiandrogen in addition to progestogen , and in relation to this, is said to have a progesterone ...
[50] [56] Combined birth control pills containing drospirenone are approved for the treatment of PMDD and may be particularly beneficial due to the antimineralocorticoid activity of drospirenone. [ 50 ] [ 57 ] [ 58 ] Studies on the influence of hormonal birth control on mood in women with existing mood disorders or polycystic ovary syndrome are ...
A recent study has shown that people who take SGLT-2 inhibitors for type 2 diabetes management have a 35% lower diabetes risk, overall. A diabetes drug may help prevent dementia, new research ...
[4] [5] [2] [3] [6] It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women. [5] The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per ...
Estradiol/drospirenone (E2/DRSP), sold under the brand name Angeliq, is a combination of estradiol (E2), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used in menopausal hormone therapy, specifically the treatment of menopausal syndrome and osteoporosis, in postmenopausal women.
Exenatide (also Exendin-4, marketed as Byetta) is the first GLP-1 agonist approved for the treatment of type 2 diabetes. Exenatide is not an analogue of GLP but rather a GLP agonist. [32] [33] Exenatide has only 53% homology with GLP, which increases its resistance to degradation by DPP-4 and extends its half-life. [34]
Ad
related to: drospirenone indications for diabetes drug resistance treatment